» Articles » PMID: 30135311

Renal Tubule Insulin Receptor Modestly Promotes Elevated Blood Pressure and Markedly Stimulates Glucose Reabsorption

Overview
Journal JCI Insight
Date 2018 Aug 24
PMID 30135311
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Although the cause of hypertension among individuals with obesity and insulin resistance is unknown, increased plasma insulin, acting in the kidney to increase sodium reabsorption, has been proposed as a potential mechanism. Insulin may also stimulate glucose uptake, but the contributions of tubular insulin signaling to sodium or glucose transport in the setting of insulin resistance is unknown. To directly study the role of insulin signaling in the kidney, we generated inducible renal tubule-specific insulin receptor-KO mice and used high-fat feeding and mineralocorticoids to model obesity and insulin resistance. Insulin receptor deletion did not alter blood pressure or sodium excretion in mice on a high-fat diet alone, but it mildly attenuated the increase in blood pressure with mineralocorticoid supplementation. Under these conditions, KO mice developed profound glucosuria. Insulin receptor deletion significantly reduced SGLT2 expression and increased urinary glucose excretion and urine flow. These data demonstrate a direct role for insulin receptor-stimulated sodium and glucose transport and a functional interaction of insulin signaling with mineralocorticoids in vivo. These studies uncover a potential mechanistic link between preserved insulin sensitivity and renal glucose handling in obesity and insulin resistance.

Citing Articles

Chronic complications of type 2 diabetes and associated factors: a cross-sectional study at the Moulay Hassan Hospital in Kenitra, Morocco.

El Aameri M, Jaghror I, Meskini N, Benchehida H, Eladha I, Chakit M Pan Afr Med J. 2025; 49:84.

PMID: 40027088 PMC: 11871885. DOI: 10.11604/pamj.2024.49.84.42930.


Insulin and the kidneys: a contemporary view on the molecular basis.

Daza-Arnedo R, Rico-Fontalvo J, Aroca-Martinez G, Rodriguez-Yanez T, Martinez-Avila M, Almanza-Hurtado A Front Nephrol. 2023; 3:1133352.

PMID: 37675359 PMC: 10479562. DOI: 10.3389/fneph.2023.1133352.


Sex Modulates Response to Renal-Tubule-Targeted Insulin Receptor Deletion in Mice.

Sohail S, Akkawi G, Rechter T, Fluitt M, Ecelbarger C Int J Mol Sci. 2023; 24(9).

PMID: 37175762 PMC: 10178497. DOI: 10.3390/ijms24098056.


Insulin Resistance and High Blood Pressure: Mechanistic Insight on the Role of the Kidney.

Brosolo G, Da Porto A, Bulfone L, Vacca A, Bertin N, Scandolin L Biomedicines. 2022; 10(10).

PMID: 36289636 PMC: 9598512. DOI: 10.3390/biomedicines10102374.


Conventional Vasopressor and Vasopressor-Sparing Strategies to Counteract the Blood Pressure-Lowering Effect of Small Interfering RNA Targeting Angiotensinogen.

Uijl E, Ye D, Ren L, Mirabito Colafella K, Van Veghel R, Garrelds I J Am Heart Assoc. 2022; 11(15):e026426.

PMID: 35876413 PMC: 9375483. DOI: 10.1161/JAHA.122.026426.


References
1.
Liu Z, Kumar A, Ota K, Wallner E, Kanwar Y . Developmental regulation and the role of insulin and insulin receptor in metanephrogenesis. Proc Natl Acad Sci U S A. 1997; 94(13):6758-63. PMC: 21231. DOI: 10.1073/pnas.94.13.6758. View

2.
Bochud M, Nussberger J, Bovet P, Maillard M, Elston R, Paccaud F . Plasma aldosterone is independently associated with the metabolic syndrome. Hypertension. 2006; 48(2):239-45. DOI: 10.1161/01.HYP.0000231338.41548.fc. View

3.
Bruning J, Michael M, Winnay J, Hayashi T, Horsch D, Accili D . A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell. 1998; 2(5):559-69. DOI: 10.1016/s1097-2765(00)80155-0. View

4.
Wang J, Barbry P, Maiyar A, Rozansky D, Bhargava A, Leong M . SGK integrates insulin and mineralocorticoid regulation of epithelial sodium transport. Am J Physiol Renal Physiol. 2001; 280(2):F303-13. DOI: 10.1152/ajprenal.2001.280.2.F303. View

5.
Arthur S, Coon S, Kekuda R, Sundaram U . Regulation of sodium glucose co-transporter SGLT1 through altered glycosylation in the intestinal epithelial cells. Biochim Biophys Acta. 2014; 1838(5):1208-14. DOI: 10.1016/j.bbamem.2014.01.002. View